Mark Naivar is the Director of Technical Innovations for Owl Biomedical, now a subsidiary of Miltenyi Biotec. Owl is producing the Tyto®, the world’s first commercial cell sorter for human therapeutics. Mr. Naivar is responsible for developing innovative new features for the Tyto®. Mr. Naivar was previously the co-founder of DarklingX, a company which developed unique data acquisition and control systems for flow cytometry applications. The clients included both academic and commercial institutions, which allowed Mr. Naivar to be active in collaborative research efforts as well as bringing innovations to market. Before DarklingX, Mr. Naivar worked as a technical staff member at Los Alamos National Laboratory as part of the National Flow Cytometry Resource, where he was active in flow cytometry R&D as well as embedded electronics and software development to support the research efforts. Mr. Naivar has a M.S. in Electrical Engineering from the University of Texas at Austin (1993) and a B.S. in Electrical Engineering from New Mexico State University at Las Cruces (1989).